Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Related Citations for PubMed (Select 24341886)

1.

Subcutaneous IgG in neurologic diseases.

Berger M.

Immunotherapy. 2014;6(1):71-83. doi: 10.2217/imt.13.146. Review.

2.

Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home.

Lucas M, Hugh-Jones K, Welby A, Misbah S, Spaeth P, Chapel H.

J Clin Immunol. 2010 May;30 Suppl 1:S84-9. doi: 10.1007/s10875-010-9400-y. Review.

PMID:
20387103
3.

Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.

Stein MR, Koterba A, Rodden L, Berger M.

Postgrad Med. 2011 Sep;123(5):186-93. doi: 10.3810/pgm.2011.09.2474.

PMID:
21904101
4.

Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.

McCormack PL.

BioDrugs. 2013 Aug;27(4):393-400. doi: 10.1007/s40259-013-0044-3. Review.

PMID:
23703447
5.

Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.

Berger M, Murphy E, Riley P, Bergman GE; VIRTUE Trial Investigators.

South Med J. 2010 Sep;103(9):856-63. doi: 10.1097/SMJ.0b013e3181eba6ea.

PMID:
20689467
6.

Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.

Berger M.

Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):532-8. doi: 10.1097/ACI.0b013e32834c22da. Review.

PMID:
21971330
7.

Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease.

Wasserman RL, Irani AM, Tracy J, Tsoukas C, Stark D, Levy R, Chen J, Sorrells S, Roberts R, Gupta S.

Clin Exp Immunol. 2010 Sep;161(3):518-26. doi: 10.1111/j.1365-2249.2010.04195.x.

8.

Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach.

Jolles S, Sleasman JW.

Adv Ther. 2011 Jul;28(7):521-33. doi: 10.1007/s12325-011-0036-y. Epub 2011 Jun 14. Review.

PMID:
21681653
9.

7(th) International Immunoglobulin Conference: Poster presentations.

Warnatz K, Ballow M, Stangel M, Bril V.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:139-40. doi: 10.1111/cei.12545.

PMID:
25546796
10.

Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.

Shapiro RS.

Ann Allergy Asthma Immunol. 2013 Jul;111(1):51-5. doi: 10.1016/j.anai.2013.04.015. Epub 2013 May 22.

PMID:
23806460
11.

[Subcutaneous immunoglobulin substitution and therapy].

Gulácsy V, Maródi L.

Orv Hetil. 2011 Jan 9;152(2):64-7. doi: 10.1556/OH.2011.28940. Hungarian.

PMID:
21177233
12.

Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.

Harbo T, Andersen H, Jakobsen J.

Neurology. 2010 Oct 12;75(15):1377-80. doi: 10.1212/WNL.0b013e3181f735ce.

PMID:
20938030
13.

Optimizing immunoglobulin G therapy in chronic autoimmune neuropathies.

Berger M.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:144-5. doi: 10.1111/cei.12547. No abstract available.

PMID:
25546798
14.

Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases.

Kanegane H, Imai K, Yamada M, Takada H, Ariga T, Bexon M, Rojavin M, Hu W, Kobayashi M, Lawo JP, Nonoyama S, Hara T, Miyawaki T.

J Clin Immunol. 2014 Feb;34(2):204-11. doi: 10.1007/s10875-013-9985-z. Epub 2014 Feb 7.

15.

Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: a multicenter study in Argentina.

Bezrodnik L, Gómez Raccio A, Belardinelli G, Regairaz L, Díaz Ballve D, Seminario G, Moreira I, Riganti C, Cantisano C, Díaz H, Di Giovanni D.

J Clin Immunol. 2013 Oct;33(7):1216-22. doi: 10.1007/s10875-013-9916-z. Epub 2013 Jul 12.

PMID:
23846854
16.

New Frontiers in Subcutaneous Immunoglobulin Treatment.

Jolles S, Stein MR, Longhurst HJ, Borte M, Ritchie B, Sturzenegger MH, Berger M.

Biol Ther. 2011 Dec 14;1:3. eCollection 2011. Review.

17.

Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.

Shapiro RS.

Pediatr Allergy Immunol. 2013 Feb;24(1):49-53. doi: 10.1111/pai.12026.

PMID:
23331529
18.

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.

Berger M, Rojavin M, Kiessling P, Zenker O.

Clin Immunol. 2011 May;139(2):133-41. doi: 10.1016/j.clim.2011.01.006. Epub 2011 Jan 23.

PMID:
21353644
19.

7th International Immunoglobulin Conference: Neurology.

Nobile-Orazio E, Lewis RA.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:22-4. doi: 10.1111/cei.12498.

PMID:
25546749
20.

Intravenous immunoglobulin in autoimmune neuromuscular diseases.

Dalakas MC.

JAMA. 2004 May 19;291(19):2367-75. Review.

PMID:
15150209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk